MENO KOUAKEU: Open Payments
NPI 1710338546 · ARLINGTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$453 in 12 payments from 8 companies in 2025. Trend: 2023 $215 · 2024 $725 · 2025 $453
Food & beverage: $453
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $151 |
| AstraZeneca Pharmaceuticals LP | 1 | $121 |
| Xeris Pharmaceuticals, Inc. | 1 | $72 |
| PFIZER INC. | 2 | $31 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $22 |
| Organon LLC | 1 | $21 |
| Novo Nordisk Inc | 1 | $18 |
| SANOFI-AVENTIS U.S. LLC | 1 | $16 |
Products named: VRAYLAR, AIRSUPRA, KEVEYIS, ELIQUIS, NEFFY, NEXPLANON, Wegovy, TZIELD.
Industry payments across VA — which companies pay providers there.
